Trends in heart failure costs for commercially insured patients in the United States (2006-2021).

ABSTRACT:

Background

Although prior research has estimated the overarching cost burden of heart failure (HF), a thorough analysis examining medical expense differences and trends, specifically among commercially insured patients with heart failure, is still lacking. Thus, the study aims to examine historical trends and differences in medical costs for commercially insured heart failure patients in the United States from 2006 to 2021.

Methods

A population-based, cross-sectional analysis of medical and pharmacy claims data (IQVIA PharMetrics^® Plus for Academic) from 2006 to 2021 was conducted. The cohort included adult patients (age > = 18) who were enrolled in commercial insurance plans and had healthcare encounters with a primary diagnosis of HF. The primary outcome measure

SUBMITTER: Zheng J 

PROVIDER: S-EPMC11232302 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature